Annual Financials for Denali Therapeutics Inc.
Assets
Fiscal year is January-December. All values USD millions. |
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Cash & Short Term Investments |
464.3M | 415.36M | 1.47B | 865.41M | 1.34B | |
Cash Only |
77.12M | 79.45M | 507.14M | 293.48M | 218.04M | |
Short-Term Investments |
- | - | - | - | - | |
Cash & Short Term Investments Growth |
- | -10.54% | 253.84% | -41.12% | 54.40% | |
Cash & ST Investments / Total Assets |
70.14% | 75.08% | 91.61% | 61.63% | 91.51% | |
Total Accounts Receivable |
8.55M | - | - | 14.93M | 5M | |
Accounts Receivables, Net |
7.36M | - | - | 13.7M | 5M | |
Accounts Receivables, Gross |
7.36M | - | - | 13.7M | 5M | |
Bad Debt/Doubtful Accounts |
- | - | - | - | - | |
Other Receivables |
1.18M | - | - | 1.23M | - | |
Accounts Receivable Growth |
- | - | - | - | -66.50% | |
Accounts Receivable Turnover |
15.11 | - | - | 3.26 | 21.69 | |
Inventories |
- | - | - | - | - | |
Finished Goods |
- | - | - | - | - | |
Work in Progress |
- | - | - | - | - | |
Raw Materials |
- | - | - | - | - | |
Progress Payments & Other |
- | - | - | - | - | |
Other Current Assets |
7.99M | 14.68M | 25.96M | 16.9M | 31.1M | |
Miscellaneous Current Assets |
1.35M | 14.68M | 25.96M | 16.9M | 31.1M | |
Total Current Assets |
480.84M | 430.03M | 1.5B | 897.23M | 1.37B | |
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Net Property, Plant & Equipment |
25.16M | 80.66M | 73.46M | 69.61M | 74.52M | |
Property, Plant & Equipment - Gross |
37.17M | 92.93M | 94.27M | 98.95M | 111.74M | |
Buildings |
- | - | - | - | - | |
Land & Improvements |
- | - | - | - | - | |
Computer Software and Equipment |
458,000 | 1.16M | 1.25M | 1.34M | 1.61M | |
Other Property, Plant & Equipment |
22.36M | 36M | 36.18M | 36.76M | 45.28M | |
Accumulated Depreciation |
12.01M | 12.27M | 20.8M | 29.34M | 37.22M | |
Total Investments and Advances |
149.38M | 41.39M | 34.2M | 426.95M | 1.5M | |
Other Long-Term Investments |
149.38M | 41.39M | 34.2M | 426.95M | 1.5M | |
Long-Term Note Receivable |
- | - | - | - | - | |
Intangible Assets |
- | - | - | - | - | |
Net Goodwill |
- | - | - | - | - | |
Net Other Intangibles |
- | - | - | - | - | |
Other Assets |
6.61M | 1.16M | 962,000 | 10.37M | 11.9M | |
Tangible Other Assets |
764,000 | 1.16M | 962,000 | 10.37M | 11.9M | |
Total Assets |
661.98M | 553.23M | 1.6B | 1.4B | 1.46B | |
Assets - Total - Growth |
- | -16.43% | 189.98% | -12.47% | 3.99% | |
Liabilities & Shareholders' Equity
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
ST Debt & Current Portion LT Debt |
- | 3.67M | 4.69M | 5.45M | 7.32M | |
Short Term Debt |
- | 3.67M | 4.69M | 5.45M | 7.32M | |
Current Portion of Long Term Debt |
- | - | - | - | - | |
Accounts Payable |
1.89M | 2.59M | 1.07M | 4.78M | 2.79M | |
Accounts Payable Growth |
- | 36.96% | -58.65% | 346.22% | -41.62% | |
Income Tax Payable |
- | - | - | - | - | |
Other Current Liabilities |
30.9M | 39.09M | 65.94M | 368.01M | 353.81M | |
Dividends Payable |
- | - | - | - | - | |
Accrued Payroll |
9.95M | 8.74M | 20.5M | 19.01M | 17.09M | |
Miscellaneous Current Liabilities |
20.94M | 30.35M | 45.44M | 349M | 336.73M | |
Total Current Liabilities |
32.79M | 45.34M | 71.7M | 378.25M | 363.92M | |
Long-Term Debt |
- | 68.87M | 64.18M | 58.55M | 53.03M | |
Long-Term Debt excl. Capitalized Leases |
- | - | - | - | - | |
Non-Convertible Debt |
- | - | - | - | - | |
Convertible Debt |
- | - | - | - | - | |
Capitalized Lease Obligations |
- | - | - | - | - | |
Provision for Risks & Charges |
- | - | - | - | - | |
Deferred Taxes |
- | - | - | - | - | |
Deferred Taxes - Credit |
- | - | - | - | - | |
Deferred Taxes - Debit |
- | - | - | - | - | |
Other Liabilities |
82.35M | 44.13M | 317.88M | 5.07M | 858,000 | |
Other Liabilities (excl. Deferred Income) |
25M | 379,000 | 701,000 | 379,000 | 379,000 | |
Deferred Income |
57.35M | 43.75M | 317.17M | 4.69M | 479,000 | |
Total Liabilities |
115.14M | 158.34M | 453.75M | 441.87M | 417.81M | |
Non-Equity Reserves |
- | - | - | - | - | |
Total Liabilities / Total Assets |
17.39% | 28.62% | 28.28% | 31.47% | 28.61% | |
Preferred Stock (Carrying Value) |
- | - | - | - | - | |
Redeemable Preferred Stock |
- | - | - | - | - | |
Non-Redeemable Preferred Stock |
- | - | - | - | - | |
Common Equity (Total) |
546.85M | 394.89M | 1.15B | 962.29M | 1.04B | |
Common Stock Par/Carry Value |
1.27M | 1.29M | 1.53M | 1.55M | 1.69M | |
Retained Earnings |
(227.94M) | (425.55M) | (354.42M) | (645M) | (970.99M) | |
ESOP Debt Guarantee |
- | - | - | - | - | |
Cumulative Translation Adjustment/Unrealized For. Exch. Gain |
- | - | - | - | - | |
Unrealized Gain/Loss Marketable Securities |
(649,000) | 350,000 | (245,000) | (2.5M) | (6.89M) | |
Revaluation Reserves |
- | - | - | - | - | |
Treasury Stock |
- | - | - | - | - | |
Common Equity / Total Assets |
82.61% | 71.38% | 71.72% | 68.53% | 71.39% | |
Total Shareholders' Equity |
546.85M | 394.89M | 1.15B | 962.29M | 1.04B | |
Total Shareholders' Equity / Total Assets |
82.61% | 71.38% | 71.72% | 68.53% | 71.39% | |
Accumulated Minority Interest |
- | - | - | - | - | |
Total Equity |
546.85M | 394.89M | 1.15B | 962.29M | 1.04B | |
Liabilities & Shareholders' Equity |
661.98M | 553.23M | 1.6B | 1.4B | 1.46B | |